ArticlePloS one

Retraction: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies.

PLOS ONE EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.